Targeted therapies have transformed the treatment landscape for non-small cell lung cancer (NSCLC) over the past decade, particularly for patients whose tumours harbour mutations in the epidermal ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) used a conference call to outline its manufacturing strategy and development ...

INSIGHT-003 demonstrates mature mOS of 30.9 months in both the overall population (N=51) and patients with TPS Outcomes continue to compare favourably with historical benchmarksPreliminary immune ...

Jinan High-tech Industrial Development Zone in Jinan, east China's Shandong Province, July 11, 2026. A staff member assembles ...

Gross SC-islet morphology and size were maintained, yet the fraction of NKX6.1-positive β cells fell substantially, pointing ...

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development ...

Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally. To overcome this ...

FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics ...

STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to ...

A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

He provided the first convincing evidence that cancerous tumors develop from a single mutated cell and later helped expose ...